DOJ Escalates False Claims Act Enforcement on Skin Substitutes

In a client alert, law firm BCLP reports that DOJ and CMS have intensified fraud enforcement targeting wound care services and skin substitute product manufacturers, citing a recent string of False Claims Act settlements. The firm notes these cases reflect sustained scrutiny of billing practices for skin substitute grafts and related wound care products, which have drawn attention due to rapidly rising Medicare and Medicaid expenditures. BCLP warns that providers, manufacturers, and distributors in this space should expect continued investigations and settlements rather than a slowdown in enforcement activity.

Finance